ACELYRIN INC. news, videos and press releases - Page 2
For more news please use our advanced search feature.
ACELYRIN INC. - More news...
ACELYRIN INC. - More news...
- DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm
- ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
- DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm
- IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm
- ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
- ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer
- ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acelyrin, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
- ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acelyrin, Inc. and Encourages Investors with Losses to Contact the Firm
- ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
